Archive ready

株式会社メディファーマによるＧＣＰ違反について｜厚生労働省

https://www.mhlw.go.jp/stf/newpage_35815.html

April 3, 2026 at 03:51 PM JST•The archive page, viewer, and downloads use this saved version.

April 3, 2026 at 03:51 PM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

株式会社メディファーマによるＧＣＰ違反について｜厚生労働省

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.mhlw.go.jp/stf/newpage_35815.html

StartedApril 3, 2026 at 03:51 PM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page is a press release from Japan's Ministry of Health, Labour and Welfare dated October 17, 2023, regarding GCP violations by Medifarma Co., Ltd. An inspection conducted from August 29 to September 4 identified multiple violations including data falsification, improper respiratory function testing, shared ID passwords among staff, and concealment of clinical trial drug storage deficiencies. The ministry instructed the company and trial sponsors to prioritize participant protection in ongoing trials. No health damage has been reported as of the announcement date.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.